EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds

Barbara C Gärtner, Dietmar Beier, Gunther Gosch, Klaus Wahle, Luise Wendt, Laura-Christin Förster, Kim J Schmidt, Tino F Schwarz

GMS Hygiene and Infection Control · 30.04.2024 · 19 (Doc21) · Doc21

DOI: 10.3205/dgkh000476 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift GMS Hygiene and Infection Control, erschienen am 30.04.2024. Verfasst von Barbara C Gärtner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Microbiology and Hygiene - Saarland University Hospital, Homburg/Saar, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Seasonal influenza poses a significant burden of disease, affecting not only older adults but also individuals under the age of 60. It carries a high economic burden, mainly driven by influenza-associated productivity losses in the working population. Conventional egg-based influenza vaccines may have reduced effectiveness due to antigen adaptation in eggs. In contrast, cell-based influenza vaccines are less likely to be affected by such antigen adaptation. This review aims to present real-world data (RWD) comparing the effectiveness of quadrivalent cell-based (QIVc) and egg-based (QIVe) influenza vaccines over three consecutive seasons.

Methods

A comprehensive review was conducted, analyzing RWD from retrospective cohort and case-control studies on the relative vaccine effectiveness (rVE) of QIVc versus QIVe during the 2017/18–2019/20 seasons.

Results

This study included six retrospective cohort studies and one case-control study, with a combined total of approximately 29 million participants. A cohort study involving people aged ≥4 years during the 2017/18 season showed a statistically significant rVE of QIVc compared to QIVe in preventing influenza-like illness, with a value of 36.2%. QIVc demonstrated statistically significant superiority over QIVe in preventing outpatient and inpatient medical encounters as observed in two cohort studies conducted during the 2018/19 and 2019/20 seasons. The rVE of QIVc compared to QIVe was found to be 7.6% in individuals aged ≥4 years and 9.5% in individuals aged ≥18 years. Three additional cohort studies conducted between 2017/18–2019/20 reported a statistically significant improvement in rVE (5.3–14.4%) of QIVc compared to QIVe in preventing influenza-related hospitalizations and emergency department visits due to influenza in individuals aged 4–64 years. In a case-control study across all three seasons, QIVc showed statistically significantly higher effectiveness compared to QIVe in preventing test-confirmed influenza, with rVEs of 10.0–14.8%.

Conclusions

RWD from the 2017/18–2019/20 seasons demonstrated that QIVc is more effective than QIVe in preventing influenza-related outcomes in individuals aged 4–64 years. Preferential use of cell-based influenza vaccines, as opposed to conventional egg-based vaccines, could reduce the burden of influenza-related symptoms on individuals and alleviate the economic impact on the German population under 60 years of age.

Schlagwörter

Stichwörter der Autor:innen

egg adaptationenhanced influenza vaccineinfluenzareal-world datavaccination recommendation

Autor:innen und Institutionen

  • Institute for Medical Microbiology and Hygiene - Saarland University Hospital, Homburg/Saar, Germany.
  • Saxon Committee on Vaccinations (SIKO), Chemnitz, Germany.
  • Kinderarztpraxis am Domplatz, Magdeburg, Germany.
  • Medical Faculty - University of Münster, Münster, Germany.
  • ias-Gruppe, Leipzig, Germany.
  • CSL Seqirus GmbH, Munich, Germany.

Zitieren

APA

Gärtner, B. C., Beier, D., Gosch, G., Wahle, K., Wendt, L., Förster, L. C., Schmidt, K. J., & Schwarz, T. F. (2024). Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds. GMS Hygiene and Infection Control, 19(Doc21), Doc21. https://doi.org/10.3205/dgkh000476

Vancouver

Gärtner BC, Beier D, Gosch G, Wahle K, Wendt L, Förster LC, et al. Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds. GMS Hygiene and Infection Control. 2024;19(Doc21):Doc21. doi:10.3205/dgkh000476

BibTeX
@article{Grtner2024,
  author = {Gärtner, Barbara C and Beier, Dietmar and Gosch, Gunther and Wahle, Klaus and Wendt, Luise and Förster, Laura-Christin and Schmidt, Kim J and Schwarz, Tino F},
  title = {Cell-based influenza vaccines: An effective vaccine option for under 60-year-olds},
  journal = {GMS Hygiene and Infection Control},
  year = {2024},
  volume = {19},
  number = {Doc21},
  pages = {Doc21},
  doi = {10.3205/dgkh000476}
}
Kostenlos starten →